These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34386888)

  • 1. Eudragit S-100 Surface Engineered Nanostructured Lipid Carriers for Colon Targeting of 5-Fluorouracil: Optimization and In Vitro and In Vivo Characterization.
    Borderwala K; Rathod S; Yadav S; Vyas B; Shah P
    AAPS PharmSciTech; 2021 Aug; 22(6):216. PubMed ID: 34386888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
    Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
    Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Mirabegron-loaded Nanostructured Lipid Carriers for Improved Bioabsorption: Formulation, Statistical Optimization, and In-Vivo Evaluation.
    Shah P; Patel M; Kansara Y; Vyas B; Prajapati P; Pradhan M; Jain S
    AAPS PharmSciTech; 2024 Sep; 25(7):222. PubMed ID: 39322792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical characterization and bioavailability assessment of 5-fluorouracil-based nanostructured lipid carrier (NLC): In vitro drug release, Hemolysis, and permeability modulation.
    Mainuddin ; Kumar A; Ratnesh RK; Singh J; Dumoga S; Sharma N; Jindal A
    Med Oncol; 2024 Mar; 41(5):95. PubMed ID: 38526657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality by design (QbD)-based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies.
    Gurumukhi VC; Bari SB
    Drug Deliv Transl Res; 2022 May; 12(5):1230-1252. PubMed ID: 34110597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers.
    Nimtrakul P; Sermsappasuk P; Tiyaboonchai W
    Drug Deliv; 2020 Dec; 27(1):1054-1062. PubMed ID: 32633144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease.
    Sinhmar GK; Shah NN; Chokshi NV; Khatri HN; Patel MM
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1078-1089. PubMed ID: 29376433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced oral bioavailability of nintedanib esylate with nanostructured lipid carriers by lymphatic targeting: In vitro, cell line and in vivo evaluation.
    Patel P; Patel M
    Eur J Pharm Sci; 2021 Apr; 159():105715. PubMed ID: 33453388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil.
    Subudhi MB; Jain A; Jain A; Hurkat P; Shilpi S; Gulbake A; Jain SK
    Materials (Basel); 2015 Feb; 8(3):832-849. PubMed ID: 28787974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan modified 5-fluorouracil nanostructured lipid carriers for treatment of diabetic retinopathy in rats: A new dimension to an anticancer drug.
    Sharma DS; Wadhwa S; Gulati M; Kumar B; Chitranshi N; Gupta VK; Alrouji M; Alhajlah S; AlOmeir O; Vishwas S; Khursheed R; Saini S; Kumar A; Parveen SR; Gupta G; Zacconi F; Chellappan DK; Morris A; Loebenberg R; Dua K; Singh SK
    Int J Biol Macromol; 2023 Jan; 224():810-830. PubMed ID: 36302483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QbD-driven development of phospholipid-embedded lipidic nanocarriers of raloxifene: extensive in vitro and in vivo evaluation studies.
    Pant A; Sharma G; Saini S; Kaur G; Jain A; Thakur A; Singh B
    Drug Deliv Transl Res; 2024 Mar; 14(3):730-756. PubMed ID: 37768530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations.
    Unnisa A; Chettupalli AK; Alazragi RS; Alelwani W; Bannunah AM; Barnawi J; Amarachinta PR; Jandrajupalli SB; Elamine BA; Mohamed OA; Hussain T
    Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.
    Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y
    Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality-by-Design-Driven Nanostructured Lipid Scaffold of Apixaban: Optimization, Characterization, and Pharmacokinetic Evaluation.
    Patil K; Gujarathi N; Sharma C; Ojha S; Goyal S; Agrawal Y
    Pharmaceutics; 2024 Jul; 16(7):. PubMed ID: 39065607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface engineered lipid nanoparticle-mediated site-specific drug delivery system for the treatment of inflammatory bowel disease.
    Sinhmar GK; Shah NN; Rawal SU; Chokshi NV; Khatri HN; Patel BM; Patel MM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):565-578. PubMed ID: 29661024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of octadecylamine-retinoic acid conjugate for enhanced cytotoxic effects of 5-FU using LDL targeted nanostructured lipid carriers.
    Varshosaz J; Hassanzadeh F; Sadeghi H; Andalib S
    Eur J Med Chem; 2012 Aug; 54():429-38. PubMed ID: 22687440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.